Clinicopathological characteristics and gene mutations in 11 patients with lipoprotein glomerulopathy

Objective Lipoprotein glomerulopathy (LPG) is a rare disorder characterized by the development of glomerular lipoprotein thrombosis. LPG exhibits familial aggregation, with mutations in the apolipoprotein E (APOE) gene identified as the leading cause of this disease. This study aimed to investigate...

Full description

Bibliographic Details
Main Authors: Yan Qin, Xiao-Jing Sun, Yi-Fang Hu, Meng Jing, Xiao-Juan Yu, Ming-Hui Zhao, Ying Tan
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Renal Failure
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/0886022X.2024.2332491
_version_ 1826860089946931200
author Yan Qin
Xiao-Jing Sun
Yi-Fang Hu
Meng Jing
Xiao-Juan Yu
Ming-Hui Zhao
Ying Tan
author_facet Yan Qin
Xiao-Jing Sun
Yi-Fang Hu
Meng Jing
Xiao-Juan Yu
Ming-Hui Zhao
Ying Tan
author_sort Yan Qin
collection DOAJ
description Objective Lipoprotein glomerulopathy (LPG) is a rare disorder characterized by the development of glomerular lipoprotein thrombosis. LPG exhibits familial aggregation, with mutations in the apolipoprotein E (APOE) gene identified as the leading cause of this disease. This study aimed to investigate APOE gene mutations and the clinicopathological features in eleven LPG patients.Methods Clinicopathological and follow-up data were obtained by extracting DNA, followed by APOE coding region sequencing analysis. This study analyzed clinical and pathological manifestations, gene mutations, treatment and prognosis.Results The mean age of the eleven patients was 33.82 years. Among them, five had a positive family history for LPG, ten presented with proteinuria, four exhibited nephrotic syndrome, and six presented with microscopic hematuria. Dyslipidemia was identified in ten patients. In all renal specimens, there was evident dilation of glomerular capillary lumens containing lipoprotein thrombi, and positive oil red O staining was observed in frozen sections of all samples. APOE gene testing revealed that one patient had no mutations, while the remaining ten patients exhibited mutations in the APOE gene, with three patients presenting with multiple mutations simultaneously. Following the confirmation of LPG diagnosis, treatment with angiotensin-converting enzyme inhibitor (ACEI)/angiotensin receptor blocker (ARB) was initiated, and the disease progressed slowly.Conclusion LPG is histologically characterized by lamellated lipoprotein thrombi in glomeruli, and kidney biopsy is essential for diagnosis. Mutations in the APOE gene are the leading cause of LPG. This study revealed clinicopathological characteristics and APOE gene mutations in patients with LPG, which helps us better understand the disease.
first_indexed 2024-04-24T12:32:08Z
format Article
id doaj.art-b011ecc95529495e9e7755e64be6ec24
institution Directory Open Access Journal
issn 0886-022X
1525-6049
language English
last_indexed 2025-02-16T19:41:01Z
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Renal Failure
spelling doaj.art-b011ecc95529495e9e7755e64be6ec242025-01-23T04:17:48ZengTaylor & Francis GroupRenal Failure0886-022X1525-60492024-12-0146110.1080/0886022X.2024.2332491Clinicopathological characteristics and gene mutations in 11 patients with lipoprotein glomerulopathyYan Qin0Xiao-Jing Sun1Yi-Fang Hu2Meng Jing3Xiao-Juan Yu4Ming-Hui Zhao5Ying Tan6Renal Division, Department of Medicine, Peking University First Hospital, Beijing, ChinaRenal Division, Department of Medicine, Peking University First Hospital, Beijing, ChinaRenal Division, Department of Medicine, Peking University First Hospital, Beijing, ChinaRenal Division, Department of Medicine, Peking University First Hospital, Beijing, ChinaRenal Division, Department of Medicine, Peking University First Hospital, Beijing, ChinaRenal Division, Department of Medicine, Peking University First Hospital, Beijing, ChinaRenal Division, Department of Medicine, Peking University First Hospital, Beijing, ChinaObjective Lipoprotein glomerulopathy (LPG) is a rare disorder characterized by the development of glomerular lipoprotein thrombosis. LPG exhibits familial aggregation, with mutations in the apolipoprotein E (APOE) gene identified as the leading cause of this disease. This study aimed to investigate APOE gene mutations and the clinicopathological features in eleven LPG patients.Methods Clinicopathological and follow-up data were obtained by extracting DNA, followed by APOE coding region sequencing analysis. This study analyzed clinical and pathological manifestations, gene mutations, treatment and prognosis.Results The mean age of the eleven patients was 33.82 years. Among them, five had a positive family history for LPG, ten presented with proteinuria, four exhibited nephrotic syndrome, and six presented with microscopic hematuria. Dyslipidemia was identified in ten patients. In all renal specimens, there was evident dilation of glomerular capillary lumens containing lipoprotein thrombi, and positive oil red O staining was observed in frozen sections of all samples. APOE gene testing revealed that one patient had no mutations, while the remaining ten patients exhibited mutations in the APOE gene, with three patients presenting with multiple mutations simultaneously. Following the confirmation of LPG diagnosis, treatment with angiotensin-converting enzyme inhibitor (ACEI)/angiotensin receptor blocker (ARB) was initiated, and the disease progressed slowly.Conclusion LPG is histologically characterized by lamellated lipoprotein thrombi in glomeruli, and kidney biopsy is essential for diagnosis. Mutations in the APOE gene are the leading cause of LPG. This study revealed clinicopathological characteristics and APOE gene mutations in patients with LPG, which helps us better understand the disease.https://www.tandfonline.com/doi/10.1080/0886022X.2024.2332491Genetic nephropathylipoprotein nephropathyApoEgene mutationdyslipidemia
spellingShingle Yan Qin
Xiao-Jing Sun
Yi-Fang Hu
Meng Jing
Xiao-Juan Yu
Ming-Hui Zhao
Ying Tan
Clinicopathological characteristics and gene mutations in 11 patients with lipoprotein glomerulopathy
Renal Failure
Genetic nephropathy
lipoprotein nephropathy
ApoE
gene mutation
dyslipidemia
title Clinicopathological characteristics and gene mutations in 11 patients with lipoprotein glomerulopathy
title_full Clinicopathological characteristics and gene mutations in 11 patients with lipoprotein glomerulopathy
title_fullStr Clinicopathological characteristics and gene mutations in 11 patients with lipoprotein glomerulopathy
title_full_unstemmed Clinicopathological characteristics and gene mutations in 11 patients with lipoprotein glomerulopathy
title_short Clinicopathological characteristics and gene mutations in 11 patients with lipoprotein glomerulopathy
title_sort clinicopathological characteristics and gene mutations in 11 patients with lipoprotein glomerulopathy
topic Genetic nephropathy
lipoprotein nephropathy
ApoE
gene mutation
dyslipidemia
url https://www.tandfonline.com/doi/10.1080/0886022X.2024.2332491
work_keys_str_mv AT yanqin clinicopathologicalcharacteristicsandgenemutationsin11patientswithlipoproteinglomerulopathy
AT xiaojingsun clinicopathologicalcharacteristicsandgenemutationsin11patientswithlipoproteinglomerulopathy
AT yifanghu clinicopathologicalcharacteristicsandgenemutationsin11patientswithlipoproteinglomerulopathy
AT mengjing clinicopathologicalcharacteristicsandgenemutationsin11patientswithlipoproteinglomerulopathy
AT xiaojuanyu clinicopathologicalcharacteristicsandgenemutationsin11patientswithlipoproteinglomerulopathy
AT minghuizhao clinicopathologicalcharacteristicsandgenemutationsin11patientswithlipoproteinglomerulopathy
AT yingtan clinicopathologicalcharacteristicsandgenemutationsin11patientswithlipoproteinglomerulopathy